Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011

Eurosurveillance

Volumn 19, Issue 11, 2014, Pages

  Jenkins, H E ^a,b   Gegia, M ^c   Furin, J ^d   Kalandadze, I ^e   Nanava, U ^c   Chakhaia, T ^c   Cohen, T ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c National Center for TB and Lung Diseases   (Georgia)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Georgia   (Georgia)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NEWBORN; QUALITY CONTROL; RISK FACTOR; RURAL AREA; SPATIAL ANALYSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; URBAN AREA;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; GEOGRAPHY; GEORGIA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84896467028     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.11.20743     Document Type: Article

References (18)

1. World Health Organization (WHO). Global Tuberculosis Report 2012. Geneva: WHO; 2012. [Accessed 9 May 2013]. Report No.: WHO/HTM/TB/2012. 6.
2. Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009; 9(3): 153-61. http://dx. doi. org/10. 1016/S1473-3099(09)70041-6.
3. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ. 2012; 90(2): 111-9D. http://dx. doi. org/10. 2471/BLT. 11. 092585.
4. National Statistics Office of Georgia. National Census Data. [Accessed 9 May 2013]. Available from: http://geostat. ge/index. php?action=page&p_id=674&lang=eng.
5. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, et al. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ. 2012; 90(1): 63-6. http://dx. doi. org/10. 2471/BLT. 11. 092320.
6. Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, et al. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J. 2013; 42(5): 1291-301. http://dx. doi. org/10. 1183/09031936. 00111812.
7. Cohen T, Manjourides J, Hedt-Gauthier B. Linking surveillance with action against drug-resistant tuberculosis. Am J Respir Crit Care Med. 2012; 186(5): 399-401. http://dx. doi. org/10. 1164/rccm. 201203-0394PP.
8. Manjourides J, Lin HH, Shin S, Jeffery C, Contreras C, Cruz JS, et al. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis (Edinb). 2012; 92(3): 273-9. http://dx. doi. org/10. 1016/j. tube. 2012. 02. 003.
9. Heifets L. Conventional methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis. In: Bastian I, Portaels F, editors. Multidrug-resistant tuberculosis. Dordrecht: Springer Netherlands; 2000. p. 133-43. http://dx. doi. org/10. 1007/978-94-011-4084-3_8.
10. World Health Organization (WHO). Treatment of tuberculosis guidelines, fourth edition. Geneva: WHO; 2010. [Accessed 9 May 2013]. Report No.: WHO/HTM/TB/2009. 420.
11. World Health Organization (WHO). Guidelines for drug resistance surveillance in tuberculosis, 4th edition. Geneva: WHO; 2009. [Accessed 9 May 2013]. Report No.: WHO/HTM/TB/2009. 422.
12. Lin H, Shin S, Blaya JA, Zhang Z, Cegielski P, Contreras C, et al. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiol Infect. 2011; 139(11): 1784-93. http://dx. doi. org/10. 1017/S0950268810002797.
13. Vashakidze L, Salakaia A, Shubladze N, Cynamon M, Barbakadze K, Kikvidze M, et al. Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia. Int J Tuberc Lung Dis. 2009; 13(9): 1148-53.
14. Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Jibuti T, Shubladze N, et al. High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis. 2008; 12(6): 635-44. http://dx. doi. org/10. 1016/j. ijid. 2008. 03. 012.
15. Aerts A, Habouzit M, Mschiladze L, Malakmadze N, Sadradze N, Menteshashvili O, et al. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis. 2000; 4(12): 1104-10.
16. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005; 60(2): 130-5. http://dx. doi. org/10. 1136/thx. 2004. 026922.
17. Dubrovina I, Miskinis K, Lyepshina S, Yann Y, Hoffmann H, Zaleskis R, et al. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? Int J Tuberc Lung Dis. 2008; 12(7): 756-62.
18. Jugheli L, Rigouts L, Shamputa IC, Bram de Rijk W, Portaels F. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. Int J Tuberc Lung Dis. 2008; 12(5): 561-6.